Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children
Background: Enuresis is defined as a normal void occurring at an inappropriate social time or place. The treatment approach for enuresis is controversial due to a lack of consensus as to the exact causes of nocturnal enuresis. Aim: Aim was to assess the efficacy of desmopressin therapy in the treatm...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2015-07-01
|
Series: | Egyptian Journal of Medical Human Genetics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1110863015000130 |
_version_ | 1818298153598713856 |
---|---|
author | Farida ElBaz Sally Zahra Marian Khairy |
author_facet | Farida ElBaz Sally Zahra Marian Khairy |
author_sort | Farida ElBaz |
collection | DOAJ |
description | Background: Enuresis is defined as a normal void occurring at an inappropriate social time or place. The treatment approach for enuresis is controversial due to a lack of consensus as to the exact causes of nocturnal enuresis.
Aim: Aim was to assess the efficacy of desmopressin therapy in the treatment of Primary Monosymptomatic Nocturnal Enuresis (PMNE) in Egyptian children.
Method: The study assessed 40 children aged 6–15 years suffering from PMNE. They were divided into 2 groups; Group 1 (20 patients) were on desmopressin tablets (0.2 mg) once daily before bedtime for 8 weeks in addition to behavioral modifications. Group 2 received only behavioral modifications. Both groups were followed up for 8 weeks of treatment, and then another 8 weeks to detect relapse.
Results: The wetting frequency decreased during treatment by 70% in Group 1 and 65% in Group 2. However, this difference was not statistically significantly different. The complete and partial response rates were 45% and 25% respectively in Group 1 and were 35% and 30% respectively in Group 2.
Conclusion: There is a highly significant decrease in wet nights in response to either desmopressin or behavioral therapy. However, the difference is not statistically significant. Also, it was found that relapsers (mainly early relapsers) are significantly more encountered in patients treated by desmopressin. |
first_indexed | 2024-12-13T04:30:48Z |
format | Article |
id | doaj.art-9e1c8dbbc0e246f484c2f5033580f23d |
institution | Directory Open Access Journal |
issn | 1110-8630 |
language | English |
last_indexed | 2024-12-13T04:30:48Z |
publishDate | 2015-07-01 |
publisher | SpringerOpen |
record_format | Article |
series | Egyptian Journal of Medical Human Genetics |
spelling | doaj.art-9e1c8dbbc0e246f484c2f5033580f23d2022-12-21T23:59:33ZengSpringerOpenEgyptian Journal of Medical Human Genetics1110-86302015-07-0116325726210.1016/j.ejmhg.2015.02.006Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian childrenFarida ElBazSally ZahraMarian KhairyBackground: Enuresis is defined as a normal void occurring at an inappropriate social time or place. The treatment approach for enuresis is controversial due to a lack of consensus as to the exact causes of nocturnal enuresis. Aim: Aim was to assess the efficacy of desmopressin therapy in the treatment of Primary Monosymptomatic Nocturnal Enuresis (PMNE) in Egyptian children. Method: The study assessed 40 children aged 6–15 years suffering from PMNE. They were divided into 2 groups; Group 1 (20 patients) were on desmopressin tablets (0.2 mg) once daily before bedtime for 8 weeks in addition to behavioral modifications. Group 2 received only behavioral modifications. Both groups were followed up for 8 weeks of treatment, and then another 8 weeks to detect relapse. Results: The wetting frequency decreased during treatment by 70% in Group 1 and 65% in Group 2. However, this difference was not statistically significantly different. The complete and partial response rates were 45% and 25% respectively in Group 1 and were 35% and 30% respectively in Group 2. Conclusion: There is a highly significant decrease in wet nights in response to either desmopressin or behavioral therapy. However, the difference is not statistically significant. Also, it was found that relapsers (mainly early relapsers) are significantly more encountered in patients treated by desmopressin.http://www.sciencedirect.com/science/article/pii/S1110863015000130Nocturnal enuresisEfficiencyDesmopressinRelapse |
spellingShingle | Farida ElBaz Sally Zahra Marian Khairy Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children Egyptian Journal of Medical Human Genetics Nocturnal enuresis Efficiency Desmopressin Relapse |
title | Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children |
title_full | Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children |
title_fullStr | Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children |
title_full_unstemmed | Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children |
title_short | Assessment of the efficacy of desmopressin in treatment of Primary Monosymptomatic Nocturnal Enuresis in Egyptian children |
title_sort | assessment of the efficacy of desmopressin in treatment of primary monosymptomatic nocturnal enuresis in egyptian children |
topic | Nocturnal enuresis Efficiency Desmopressin Relapse |
url | http://www.sciencedirect.com/science/article/pii/S1110863015000130 |
work_keys_str_mv | AT faridaelbaz assessmentoftheefficacyofdesmopressinintreatmentofprimarymonosymptomaticnocturnalenuresisinegyptianchildren AT sallyzahra assessmentoftheefficacyofdesmopressinintreatmentofprimarymonosymptomaticnocturnalenuresisinegyptianchildren AT mariankhairy assessmentoftheefficacyofdesmopressinintreatmentofprimarymonosymptomaticnocturnalenuresisinegyptianchildren |